experspadmin

Optimizing the Approach to Treatment-Naive Chronic Lymphocytic Leukemia
Oncology

Optimizing the Approach to Treatment-Naive Chronic Lymphocytic Leukemia

patient care perspectives
By Matthew S. Davids, MD, MMSc
Minimal Residual Disease and Plasma Biomarkers in Chronic Lymphocytic Leukemia: Today and Tomorrow
Oncology

Minimal Residual Disease and Plasma Biomarkers in Chronic Lymphocytic Leukemia: Today and Tomorrow

clinical topic updates
By William G. Wierda, MD, PhD
Fixed-Duration Combination Therapy vs Indefinite Therapy for Chronic Lymphocytic Leukemia
Oncology

Fixed-Duration Combination Therapy vs Indefinite Therapy for Chronic Lymphocytic Leukemia

clinical topic updates
Novel Treatments for Patients With Advanced Gastrointestinal Stromal Tumors
Oncology

Novel Treatments for Patients With Advanced Gastrointestinal Stromal Tumors

expert roundtables
By Arun Singh, MD; Jonathan C. Trent, MD, PhD; Michael C. Heinrich, MD
Pathologic and Molecular Risk Stratification in Patients With Gastrointestinal Stromal Tumors
Oncology

Pathologic and Molecular Risk Stratification in Patients With Gastrointestinal Stromal Tumors

patient care perspectives
By Michael C. Heinrich, MD
Load More